Autoimmune rheumatological disorders Flashcards
Examples
- Systemic Lupus Erythematosus
- Antiphospholipid syndrome
- Sjogrens syndrome
- Polymyositis (and dermatomyositis)
Describe Systemic Lupus Erythematosus
An inflammatory, hetergenous, multisystem autoimmune disorder with antinuclear antibodies as wells as arthralgia and rashes
as the most common clinical features, and cerebral and renal disease as the
most serious problems.
Clinical presentation of Systemic Lupus Erythematosus
General:
Fatigue, Photo-sensitive rash, malaise, fever, splenomegaly, lymphadenopathy, pleuritic chest pain, headache, Raynaud’s. mild hair loss myalgia
*Erythema in a Butterfly distribution on the cheeks of the face and across the bridge of the nose
*Arthralgia: (like RA)
Symmetrical joint and muscle pain
Mucocutaneous:
Discoid lupus, potosensitive rash, *butterfly rash
Pulmonary:
Pleurisy, Fibrosing alveolitis, obliterative bronchiolitis
CVS:
Pericarditis, hypertension
Renal:
Nephritis, Haematuria, *glomerulonephritis
Neuro:
Anxiety and depression
Pathophysiology of Systemic Lupus Erythematosus
Apoptotic cells and cell fragments are cleared inefficiently by phagocytes
- > transfer to lymphoid tissue
- > taken up by antigen presenting cells
- > self-antigens including nuclear components are presented to T cells
- > T cells stimulate B cells to produce autoantibodies against the antigens.
Clinical manifestations are mediated by antibody formation and the development and deposition of immune complexes, complement activation and influx of neutrophils and abnormal cytokine production.
Aetiology of Systemic Lupus Erythematosus
Unknown
Likely multifactorial
Strong genetic association (HLA genes have been linked or family hx)
UV light (onset of rash)
Epstein-Barr virus can also trigger SLE
Higher incidence premenopausal (oestrogen has an effect)
Epidemiology of Systemic Lupus Erythematosus
More common in premenopausal females
Peak age of onset between 20-40 years (typically child bearing age)
More common in Asians and African-Caribbeans
Diagnostic tests of Systemic Lupus Erythematosus
FBC
ESR
Antinuclear factor
Treatment of Systemic Lupus Erythematosus
Avoid sunlight and smoking
NSAIDs and corticosteroid for arthralgia
Immunosuppressives for severe symptoms
Rituximab
Complications of Systemic Lupus Erythematosus
Depends on organ involvement
Characterised by relapse and remission
Describe Antiphospholipid syndrome
Autoimmune disorder characterised by arterial and venous thrmobosis and raised levels of antiphospholipid antibodies
Clinical presentation of Antiphospholipid syndrome
Varied clinical features Coagulation problems; Livedo reticularis; Obstetric problems; Thrombocytopenia
Also Peripheral artery thrombosis, deep venous thrombosis, cerebrovascular disease, pregnancy loss, MI, retinal thrombosis, pulmonary embolism and pulmonary hypertension
Pathophysiology of Antiphospholipid syndrome
Proposed mechanisms for hypercoagulable effect of aPL-antibodies include complement activation, the production of antibodies against coagulation factors, activation of platelets, activation of vascular endothelium and a reaction of antibodies to oxidised low density lipoprotein
Aetiology of Antiphospholipid syndrome
Unknown - some genetic association
Epidemiology of Antiphospholipid syndrome
Higher prevalence in black people
Occurs most commly in women of fertile age
Diagnostic test of Antiphospholipid syndrome
Screen for aPL antibodies